SRDX Snapshot | |
---|---|
Surmodics, Inc. provides surface modification technologies for intravascular medical devices and chemical components for microarray and in vitro diagnostic immunoassay tests in the United States and internationally. The company is headquartered in Eden Prairie, Minnesota. | |
VALUATION DATA | |
Market Capitalization | $409,997,000 | Price to Sales | 0.00 |
Earnings per Share | $0.3900 |
PE Ratio | 73.85 |
PRICE DATA | |
Most Recent Close | $28.8000 |
52 Week High | $2.967 |
52 Week Low | $3.368 |
50-Day Moving Average | $2.967 |
200-Day Moving Average | $18.59 |
All data are from Alpha Vantage as of today. For more infomation on SRDX see Stock Dividend, Valuation, Price and Financial Data for Investors |